BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 36513140)

  • 21. Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling.
    Koskinen C; Persson E; Baldock P; Stenberg Å; Boström I; Matozaki T; Oldenborg PA; Lundberg P
    J Biol Chem; 2013 Oct; 288(41):29333-44. PubMed ID: 23990469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notch in skeletal physiology and disease.
    Canalis E
    Osteoporos Int; 2018 Dec; 29(12):2611-2621. PubMed ID: 30194467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-κB.
    Zhang H; Hilton MJ; Anolik JH; Welle SL; Zhao C; Yao Z; Li X; Wang Z; Boyce BF; Xing L
    J Clin Invest; 2014 Jul; 124(7):3200-14. PubMed ID: 24892805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome.
    Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E
    J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible roles of insulin signaling in osteoblasts.
    Pramojanee SN; Phimphilai M; Chattipakorn N; Chattipakorn SC
    Endocr Res; 2014; 39(4):144-51. PubMed ID: 24679227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of Notch modulators, tetraspanin 5 and 10, inhibits osteoclastogenesis in vitro.
    Zhou J; Fujiwara T; Ye S; Li X; Zhao H
    Calcif Tissue Int; 2014 Sep; 95(3):209-217. PubMed ID: 24935633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The developmental biology of genetic Notch disorders.
    Mašek J; Andersson ER
    Development; 2017 May; 144(10):1743-1763. PubMed ID: 28512196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Notch signaling in bone formation and related skeletal diseases].
    Ma H; Wu Y; Zhang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Apr; 32(2):274-9. PubMed ID: 25863103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Autophagy and Mitophagy in Bone Metabolic Disorders.
    Wang S; Deng Z; Ma Y; Jin J; Qi F; Li S; Liu C; Lyu FJ; Zheng Q
    Int J Biol Sci; 2020; 16(14):2675-2691. PubMed ID: 32792864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch Signaling in Skeletal Development, Homeostasis and Pathogenesis.
    Zieba JT; Chen YT; Lee BH; Bae Y
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32092942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch inhibits osteoblast differentiation and causes osteopenia.
    Zanotti S; Smerdel-Ramoya A; Stadmeyer L; Durant D; Radtke F; Canalis E
    Endocrinology; 2008 Aug; 149(8):3890-9. PubMed ID: 18420737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.
    Geoffroy V; Kneissel M; Fournier B; Boyde A; Matthias P
    Mol Cell Biol; 2002 Sep; 22(17):6222-33. PubMed ID: 12167715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
    Baum R; Gravallese EM
    Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hedgehog signaling in mature osteoblasts regulates bone formation and resorption by controlling PTHrP and RANKL expression.
    Mak KK; Bi Y; Wan C; Chuang PT; Clemens T; Young M; Yang Y
    Dev Cell; 2008 May; 14(5):674-88. PubMed ID: 18477451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of Notch signaling in skeletal development and disease.
    Tao J; Chen S; Lee B
    Ann N Y Acad Sci; 2010 Mar; 1192():257-68. PubMed ID: 20392245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoblast lineage-specific effects of notch activation in the skeleton.
    Canalis E; Parker K; Feng JQ; Zanotti S
    Endocrinology; 2013 Feb; 154(2):623-34. PubMed ID: 23275471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic inhibition of canonical Notch signaling results in sustained callus inflammation and alters multiple phases of fracture healing.
    Dishowitz MI; Mutyaba PL; Takacs JD; Barr AM; Engiles JB; Ahn J; Hankenson KD
    PLoS One; 2013; 8(7):e68726. PubMed ID: 23844237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling.
    Canalis E; Adams DJ; Boskey A; Parker K; Kranz L; Zanotti S
    J Biol Chem; 2013 Aug; 288(35):25614-25625. PubMed ID: 23884415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E-selectin ligand 1 regulates bone remodeling by limiting bioactive TGF-β in the bone microenvironment.
    Yang T; Grafe I; Bae Y; Chen S; Chen Y; Bertin TK; Jiang MM; Ambrose CG; Lee B
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7336-41. PubMed ID: 23589896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.